Neurocysticercosis

Emerging Neurological Infections

Volumn , Issue , 2005, Pages 261-289

  Davis, Larry E ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745701615     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (107)

1. Bern C, Garcia H, Evans C, et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 1999; 29:1203-1209.
2. Medina MT, Roasa E, Rubio-Donnadieuy F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990; 150:325-327.
3. Roberts T, Murrell KD, Marks S. Economic losses caused by food borne parasitic diseases. Parasitol Today 1994; 11:419-423.
4. Lombardo L, Mateos JH. Cerebral cysticercosis in Mexico. Neurology 1961; 11:824-828.
5. Schenone H, Villarroel F, Rojas A, Ramirez R. Epidemiology of human cysticercosis in Latin America. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltran F, eds. Cysticercosis: Present State of Knowledge and Perspectives. New York, Academic Press, 1982:25-38.
6. Schultz TS, Ascherl GF. Cerebral cysticercosis: occurrence in the immigrant population. Neurosurgery 1978; 3:164-169.
7. Dixon HBF, Lipscomb FM. Cysticercosis: An Analysis and Follow-Up of 450 Cases. Privy Council, Medical Research Council Special Report Series, No. 299. London:Her Majesty’s Stationery Office, 1961:1-58.
8. Wei G-Z, Li C-J, Meng J-M, Ding, M-C. Cysticercosis of the central nervous system. Chin Med J 1988; 101:493-500.
9. Sarti E, Schantz PM, Plancarte A, et al. Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico. Am J Trop Med Hyg 1992; 46:677-685.
10. Stepien L. Cerebral cysticercosis in Poland: clinical symptoms and operative results in 132 cases. J Neurosurg 1962; 19:505-513.
11. Sorasuchart A, Khunadorn N, Edmeads J. Parasitic diseases of the nervous system in Thailand. Can Med Assoc J 1968; 98:859-867.
12. Richards FO, Schantz PM, Ruiz-Tiben E, Sorvillo FJ. Cysticercosis in Los Angeles county. JAMA 1985; 254:3444-3448.
13. Ong S, Talan DA, Moran GJ, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002; 8:608-613.
14. Schantz PM, Moore AC, Munoz JL, et al. Neurocysticercosis in an orthodox Jewish community in New York City. N Engl J Med 1992; 327:692-695.
15. Pittella JEH. Neurocysticercosis. Brain Pathol 1997; 7:681-693.
16. Lawson Jr, Gremmell MA. Hydatidosis and cysticercosis: the dynamics of transmission. Adv Parasitol 1983; 22:261-308.
17. McCormick GF, Zee C-S, Heiden J. Cysticercosis cerebri: review of 127 cases. Arch Neurol 1982; 39:534-539.
18. Loo L, Braude A. Cerebral cysticercosis in San Diego: a review of 23 cases and a review of the literature. Medicine 1982; 61:341-359.
19. Thomas JA, Knoth R, Volk B. Disseminated human neurocysticercosis. Acta Neuropathol 1989; 78:594-604.
20. Davis LE, Kornfeld M. Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects. Eur Neurol 1991; 31:229-240.
21. Davis LE. Neurocysticercosis: pathology, diagnosis, and management. Neurologist 1996; 2:356-364.
22. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms. Arch Intern Med 1985; 145:442-445.
23. Carpio A, Placencia M, Santillan F, Escobar A. A proposal for classification of neurocysticercosis. Can J Neurol Sci 1994; 21:43-47.
24. Thomas JA, Knoth R, Volk B. Disseminated human neurocysticercosis. Acta Neuropathol 1989; 78:594-604.
25. Wadia N, Sesai S, Bhatt M. Disseminated cysticercosis. Brain 1988; 111:597-614.
26. Rangel R, Torres B, Del Bruto O, Sotelo J. Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg 1987; 36:387-392.
27. Kramer LD, Locke GE, Byrd SE, Daryabagi J. Cerebral cysticercosis: documentation of natural history with CT. Radiology 1989; 171:459-462.
28. Gilman RH, Del Brutto OH, Garcia HH, Martinez M, Cysticercosis Working Group in Peru. Prevalence of taeniasis among patients with neurocysticercosis is related to severity of infection. Neurology 2000; 55:1062.
29. Escobar A. The pathology of neurocysticercosis. In: Palacios E, Rodriguez-Carbajal J, Taveras JM, eds. Cysticercosis of the Central Nervous System. Springfield:Thomas, 1983:27-59.
30. White AC Jr, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol 1997; 66:209-230.
31. Leid RW, Suquet CM, Tanigoshi L. Parasite defense mechanisms for evasion of host attack: a review. Vet Parasitol 1987; 25:147-162.
32. Leid RW, Grant RF, Suquet CM. Inhibition of equine neutrophil chemotaxis and chemokinesis by a Taenia taeniaeformis proteinase inhibitor, taeniaestin. Parasite Immunol 1987; 9:195-204.
33. Larralde C, Montoya RM, Sotelo J, et al. Murine T. crassiceps antigens in immunodiagnosis of T. solium human neurocysticercosis, T. saginata bovine cysticercosis, and human E. Granulosus hydatidosis. Bull Soc Fr Parasitol 1990; 8:S8B.
34. Leid RW, Suquet CM, Tanigoshi L. Oxygen detoxifying enzymes in parasites: a review. Acta Leiden 1989; 57:107-114.
35. Leid RW, Suquet CM. A superoxide dismutase of metacestode of Taenia taeniaformis. Mol Biochem Parasitol 1986; 18:301-311.
36. Tato P. Castro AM, Rodriguez D, Soto R, Arachavaleta F, Molinari JL. Suppression of murine lymphocyte proliferation induced by a small RNA purified from the Taenia solium metacestode. Parasitol Res 1995; 81:181-187.
37. Arechavaleta F, Molinari LM, Tato P. A Taenia solium metacestode factor nonspecifically inhibits cytokine production. Parasitol Res 1998; 84:117-122.
38. Rolfs A, Muhschlegel F, Jansen-Rosseck R, et al. Clinical and immunologic followup study of patients with neurocysticercosis after treatment with praziquantel. Neurology 1995; 45:532-538.
39. Del Brutto OH, Sotelo J, Aguirre R, Diaz-Calderon E, Alarcon TA. Albendazole therapy for giant subarachnoid cysticerci. Arch Neurol 1992; 49:535-538.
40. Estanol B, Juarez H, Irigoyen MDC, Gonzalez-Barranco D, Corona T. Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. Neurol Neurosurg Psychiatry 1989; 52:254-257.
41. Robinson P, Atmar RL, Lewis DE, White AC Jr. Granuloma cytokines in murine cysticercosis. Infect Immunol 1997; 65:2925-2931.
42. Rejshekhar V. Rate of spontaneous resolution of a solitary cysticercus granuloma in patients with seizures. Neurology 2001; 57:2315-2317.
43. Earnest MP, Reller LB, Filley CM, Grek AJ. Neurocysticercosis in the United States:35 cases and a review. Rev Infect Dis 1987; 9:961-979.
44. Shandera WX, White AC, Chen JC, Diaz P, Armstrong R. Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine 1994; 73:37-52.
45. White AC Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997; 24:101-115.
46. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992; 42:389-392.
47. Castillo M, Quencer RM, Post JD. MR of intramedullary spinal cysticercosis. AJNR Am J Neuroradiol 1988; 9:393-395.
48. Akiguchi I, Fujiwara T, Matsuyama H. Intramedullary spinal cysticercosis. Neurology 1979; 29:1531-1534.
49. McDonald JB, Turner PT, Miller AH. Cysticercosis and spinal cord compression. Ann Neurol 1979; 6:367-368.
50. Garcia HH, Evans CAW, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002; 15:747-756.
51. Zee C-S, Segall HD, Boswell W, Ahmadi J, Nelson M, Colletti P. MR imaging of neurocysticercosis. J Comput Assist Tomogr 1988; 12:927-934.
52. Suss RA, Maravilla KRT, Thompson J. MR imaging of intracranial cysticercosis:comparison with CT and anatomopathologic features. AJNR Am J Neuroradiol 1986; 7:234-242.
53. Vazquez V, Sotello J. The course of seizures after treatment for cerebral cysticercosis. N Eng J Med 1992; 327:696-701.
54. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004; 350:249-58.
55. Bickerstaff ER, Cloake PCP, Hughes B, Smith WT. The racemose form of cerebral cysticercosis. Brain 1952; 75:1-18.
56. Valkounova J, Zdarska Z, Slais J. Histochemistry of the racemose form of Cysticercus cellulosae. Folia Parasitol (Praha) 1992; 39:207-226.
57. Sotelo J, Marin C. Hydrocephalus secondary to cysticercotic arachnoiditis. A longterm follow-up review of 92 cases. J Neurosurg 1987; 66:686-689.
58. Esberg G, Reske-Nielsen R. Sudden death from cerebral cysticercosis. Scand J Infect Dis 1988; 20:679-884.
59. Del Brutto OH. Cysticercosis and cerebrovascular disease: a review. J Neurol Neurosurg Psychiatr 1992; 55:252-254.
60. Alarcon F, Hidalgo F, Moncayo J, Vinan I, Duenas G. Cerebral cysticercosis and stroke. Stroke 1992; 23:224-228.
61. Rodacki MA, Detoni XA, Teixeira WR, Boer VH, Oliveira GG. CT features of cellulosae and racemosus neurocysticercosis. J Comput Assist Tomogr 1989; 13:1013-1016.
62. Kelley R, Duong DH, Locke GE. Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery 2002; 50:757-762.
63. Ginier BL, Poirier VC. MR imaging of intraventricular cysticercosis. AJNR Am J Neuroradiol 1992; 13:1247-1248.
64. Apuzzo MLJ, Dobkin WR, Zee C-S, Chan JC, Giannotta SL, Weiss MH. Surgical considerations in treatment of intraventricular cysticercosis. An analysis of 45 cases. J Neurosurg 1984; 60:400-407.
65. Madrazo I, Garcia-Renteria JA, Sandoval M, Lopez Vega F. Intraventricular cysticercosis. Neurosurgery 1983; 12:148-152.
66. Cuetter AC, Garcia-Bobadilla J, Guerra LG, Martinez FM, Kaim B. Neurocysticercosis: focus on intraventricular disease. Clin Infect Dis 1997; 24:157-164.
67. Kramer J, Carrazana EJ, Cosgrove GR, Kleefield J, Edelman RR. Transaqueductal migration of a neurocysticercus cyst. J Neurosurg 1992; 77:956-958.
68. Pushker N, Bajaj MS, Chandra M. Ocular and orbital cysticercosis. Acta Ophthalmol Scand 2001; 79:408-413.
69. Cardenas F, Quiroz H, Plancarte A, Meza A, Dalma A, Flisser A. Taenia solium ocular cysticercosis: findings in 30 cases. Ann Ophthalmol 1992; 24:25-28.
70. Sihota R, Honavar SG. Oral albendazole in the management of extraocular cysticercosis. Br J Ophthalmol 1994; 78:621-623.
71. Sekhar GC, Lemke BN. Orbital cysticercosis. Ophthalmology 1997; 104:1599-1604.
72. Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand 1991; 84:465-470.
73. Scharf D. Neurocysticercosis. Arch Neurol 1988; 45:777-780.
74. Greenlee JE, Carroll KC. Cerebrospinal fluid in CNS infections. In: Scheld WM, Whitley RJ, Durack DT, eds. Infections of the Central Nervous System. 2nd ed. Philadelphia: Lippincott-Raven, 1997:899-922.
75. Gekeler F, Eichenlaub S, Mendoza EG, Sotelo J, Hoelscher M, Loscher T. Sensitivity and specificity of ELISA and immunoblot for diagnosing neurocysticercosis. Eur J Clin Microbiol Infect Dis 2002; 21:227-229.
76. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, Tsang VCW. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991; 164:1007-1009.
77. Garcia HH, Herrera G, Gilman RH, Tsang VC, Pilcher JB, Diaz JF, et al. Discrepancies between cerebral computed tomography and western blot in the diagnosis of neurocysticercosis. Am J Trop Med Hyg 1994; 50:152-157.
78. Ramos-Kuri M, Montoya RS, Padilla A, et al. Immunodiagnosis of neurocysticercosis:disappointing performance of serology (ELISA) in an unbiased sample of neurologic patients. Arch Neurol 1992; 49:633-636.
79. Garcia HH, Harrison LJ, Parkhouse RM, et al. A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg 1998; 92:411-414.
80. Garcia HH, Parkhouse RM, Gilman RH et al. Serum antigen detection in the diagnosis, treatment and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg 2002; 94:673-676.
81. Garcia HH, Gonzalez AE, Gilman RH, et al. Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis. Am J Trop Med Hyg 2002; 66:427-430.
82. Sotelo J, Jung H. Pharmacokinetic optimization of the treatment of neurocysticercosis. Clin Pharmacokinet 1998; 34:503-515.
83. Jung H. Hurtado M, Medina MT, Sanchez M, Sotello J. Dexamethasone increases plasma levels of albendazole. J Neurol 1990; 237:279-280.
84. Overbosch D, van de Nes JCM, Groll E, Diekmann HW, Polderman AM, Mattie H. Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis. Eur J Clin Pharmacol 1987; 33:287-292.
85. King CH, Mahmoud AAF. Drugs five years later: praziquantel. Ann Intern Med 1989; 110:290-296.
86. Vasquez ML, Jung H, Sotelo J. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology 1987; 37:1561-1562.
87. Sotelo J, Escobedo F, Rodriguez-Carbajal J, Torres B, Rubio-Donnadieu F. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 1984; 310:1001-1007.
88. Bittencourt PRM, Carcia CM, Martins R, Fernandes AG, Diekman HW, Jung W. Phenytoin and carbamazepine decrease oral bioavailability of praziquantel. Neurology 1992; 42:492-496.
89. Castro N, Medina R, Sotelo J, Jung H. Bioavailability of praziquantel increases with concomitant administration of food. Antimicrob Agents Chemother 2000; 44:2903-2904.
90. Proano JV, Madrazo I, Avelar F, Lopez-Felix B, Diaz G, Grijalva I. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 1001; 345:879-885.
91. Davis LE. Neurocysticercosis and seizures: avoiding the cost of antihelminthic treatment. Neurology 2002; 59:1669.
92. Del Brutto OH, Sotelo J, Roman GC. Therapy for neurocysticercosis: a reappraisal. Clin Infect Dis 1993; 17:730-735.
93. Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol 2000; 15:207-213.
94. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994; 44:1344-1346.
95. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis 1998; 7:696-700.
96. Carpio A, Santillan F, Leon P, Flores C, Hauser WA. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995; 155:1982-1988.
97. Salinas R, Prasad K. Drugs for treating neurocysticercosis (tapeworm infection of the brain) [Cochrane Review]. Cochrane Database Syst Rev 2000; 2:CD00215.
98. Sotelo J, Marin C. Hydrocephalus secondary to cysticercotic arachnoiditis. A longterm follow-up review of 92 cases. J Neurosurg 1987; 66:686-689.
99. Keane JR. Death from cysticercosis: seven patients with unrecognized obstructive hydrocephalus. West J Med 1984; 140:787-789.
100. Del Brutto OH, Sotelo J. Albendazole therapy for subarachnoid and ventricular cysticercosis:case report. J Neurosurg 1990; 72:816-817.
101. Bergsneider M, Holly LT, Lee JH, King WA, Frazee FG. Endoscopic management of cysticercal cysts within the lateral and third ventricles. J Neurosurg 2000; 92:14-23.
102. Roman S, Soto-Hernandez JL, Sotelo J. Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis. A preliminary study. J Neurosurg 1996; 84:629-633.
103. Biagi F, Velez G, Gutierrrez ML. Destruccion de los cisticercos en la carne de cerdo prensa. Med Mex 1963; 28:253-257.
104. Sotelo J, Rosas N, Palencia G. Freezing of infested pork muscle kills cysticerci. JAMA 1986; 256:893-894.
105. Lightowlers MW, Gauci CG. Vaccines against cysticercosis and hydatidosis. Vet Parasitol 2001; 101:337-352.
106. Lightowlers MW. Eradication of Taenia solium cysticercosis: a role for vaccination of pigs. Int J Parasitol 1999; 29:811-817.
107. Garcia-Noval J, Allan JC, Fletes C, et al. Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg 1996; 55:282-289.